[Bronchiolitis with airflow obstruction in adults].
OBJECTIVE
The purpose of this paper is twofold: to describe the clinical and anatomical characteristics of bronchiolitis associated with airflow obstruction in adults; to present through a clinical approach, a classification of the main aetiologies or pathological frames associated with that entity.


CONCLUSIONS
The constrictive bronchiolitis type is the most frequently encountered. On clinical grounds, cough, crackles, and a progressive dyspnea develop usually within a few weeks. Radiological signs of bronchiolar abnormalities are best visualized on high resolution expiratory CT scan. The decrease in maximal airflows and oxygen tension is of limited amplitude and poorly reversible with bronchodilators. Diagnosis is easily performed when a causative event, or the clinical context, can be delineated: inhalation of toxic fumes, diffuse bronchiectasis, rheumatoid arthritis, lung or bone marrow transplantation. Delayed formation of bronchiectasis in the central airways is common. The treatment is not standardized; corticosteroids are usually prescribed as a first line therapy; the benefit of the addition of, or substitution with immunosuppressive drugs has not been adequately evaluated, but is, on the mean, of limited amplitude.


CONCLUSIONS
Recent advances in the identification of inhaled agents toxic for the distal airways help in establishing appropriate measures of prevention. When the aetiology of the bronchiolitis cannot be suspected, extensive search of a causative agent should be performed, including microbial and mineral analysis of bronchoalveolar products. Negative results should lead to perform a surgical lung biopsy. The study of chronic rejection processes in animal models of lung transplantation, the identification of inhibitory factors of bronchiolar fibrogenesis, and the efficacy of some anti-cytokines on inflammatory processes could result in new therapeutic approaches.
Fournier
M
M
Service de pneumologie et réanimation respiratoire, hôpital Beaujon, AP-HP, 100, boulevard du Général-Leclerc, 92110 Clichy, France. michel.fournier@bjn.ap-hop-paris.fr
Marceau
A
A
Dauriat
G
G
Camuset
J
J
Groussard
O
O
D000328:Adult; D000402:Airway Obstruction / Q000209:etiology*; D000818:Animals; D001988:Bronchiolitis / Q000150:complications* / Q000209:etiology / Q000473:pathology*; D016207:Cytokines / Q000494:pharmacology; D003937:Diagnosis, Differential; D004195:Disease Models, Animal; D006801:Humans; D007249:Inflammation; D019570:Inhalation Exposure; D014057:Tomography, X-Ray Computed
D016207:Cytokines